期刊文献+

联合应用蒲参胶囊和泼尼松治疗原发性肾病综合征的临床观察

Treatment of Pushen Capsule and Prednisone in primary nephrotic syndrome patients
下载PDF
导出
摘要 目的观察联合蒲参胶囊和泼尼松治疗原发性肾病综合征的临床疗效。方法 72例肾病综合征患者随机分成两组,泼尼松组(对照组)、蒲参胶囊组(泼尼松+蒲参胶囊),观察两组患者治疗前后尿蛋白、血浆白蛋白、血脂变化。结果两组治疗后均见尿蛋白减少,血浆白蛋白升高和总胆固醇、甘油三酯下降(P<0.01),但蒲参胶囊组和对照组相比,蒲参胶囊组作用尤为明显(P<0.01)。结论蒲参胶囊能减少尿蛋白量,提高血浆白蛋白,降低血脂。 Objective: To observe therapeutic effect of Pushen Capsule and Prednisone in treatment of primary nephrotic sysdrome. Methods: Seventy-two patients were divided into two groups at random: Group A was treated with Prednisone,and Group B treated with Prednisone and Pushen Capsule. The changes in their urine,protein,serum albumin and blood fat after the treatment were observed. Results: The decrease of urine protein,increase of serum albumin and lowering in total cholesterol and triglyceride were found in the two groups( P〈 0. 01). The group treated with Pushen Capsule are more significant than the other group( P〈 0. 01). Conclusion: Pushen Capsule can decrease urine protein,increase serum albumin and lower blood fat level.
出处 《泰山医学院学报》 CAS 2014年第11期1135-1137,共3页 Journal of Taishan Medical College
关键词 蒲参胶囊 泼尼松 肾病综合征 Pushen Capsule Prednisone nephrotic syndrome
  • 相关文献

参考文献13

二级参考文献41

  • 1吴圣贤,刘宗莲,高改地.蒲参胶囊治疗原发性高脂血症的多中心随机平行对照临床试验[J].北京中医药大学学报,2005,28(2):80-82. 被引量:14
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33041
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
  • 4国际心脏病学会和协会及世界卫生组织临床命名标准化联合专题组.缺血性心脏病的命名及诊断标准[J].中华心血管病杂志,1981,9(2):75-75.
  • 5Karpe F, Steiner G, Uffelman K, et al. Postprandial lpoproteins and progression of coronarz atherosclerosis, Atherosclerosis, 1994, 106:83~97.
  • 6方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067
  • 7Lassila M, Fukami K, Jandeleit - Dahm K, et al. Plasminogen ac- tivator inhibitor- 1 production is pathogenetic in experimental murine diabetic renal disease. Diabetologia,2007,50 (6) : 1315 - 1326.
  • 8Rademacher E, Mauer M, Jacobs DR Jr, et al. Albumin excretion rate in normal adolescents: relation to insulin resistance and car- diovascular risk factors and comparisons to type 1 diabetes melli- tus patients. Clin J Am Soc Nephrol,2008,3(4) :998 - 1005.
  • 9Phillips PJ, Phillipov G. Diabetes monitorin - albuminura fre- quently asked questions. Aust Fam Physician, 2007,36 ( 9 ) : 713 -715.
  • 10Van Huyen JP, Viltard M, Nehiri T, et al. Expression of matrix metalloproteinases MMP- 2 and MMP- 9 is altered during nephrogenesis in fetuses from diabetic rats. Lab Invest, 2007,87 (7) :680 -689.

共引文献1765

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部